Cancer

The landscape of anal squamous cell carcinoma (ASCC), a rare yet increasingly prevalent malignancy, is undergoing a profound transformation fueled...

The relentless challenge posed by glioblastoma multiforme (GBM), the most aggressive and lethal primary brain tumor, continues to galvanize oncological...

Immune checkpoint inhibitors (ICIs) have rapidly transformed the landscape of oncology by harnessing the body’s immune system to combat malignancies....

In a groundbreaking study published in BMC Cancer, researchers unveil the pivotal role of a circular RNA, circSLC22A3, in suppressing...

As of January 1, 2025, it is estimated that nearly 18.6 million individuals in the United States are living with...

In a groundbreaking advancement that could redefine the prognosis for a challenging subset of metastatic colorectal cancer (mCRC) patients, the...

Researchers from Mass General Brigham are poised to unveil groundbreaking advancements in cancer therapy and supportive care at the 2025...

In a groundbreaking fusion of computational engineering and immunotherapy, Dr. Natasa Miskov-Zivanov, an assistant professor of electrical and computer engineering...

A groundbreaking advancement in cancer therapeutics is emerging from a recent international clinical trial investigating the novel targeted therapy, DB-1310....

Central to this breakthrough is the use of a thermo-ionically reversible hydrogel system, enabling the encapsulation of human salivary gland...

In a groundbreaking study that redefines our understanding of chromosome architecture, researchers from the Institute of Science Tokyo have unveiled...

In a groundbreaking study published in the prestigious journal Radiology: Imaging Cancer, a comprehensive analysis reveals that the method by...

In a groundbreaking new study poised to reshape our understanding of laryngeal squamous cell carcinoma (LSCC), researchers have unveiled a...

In a groundbreaking advancement for colorectal cancer treatment, recent data from the Phase III BREAKWATER trial heralds a new era...

In the relentless quest to unravel the complex biological factors contributing to colorectal cancer, a recent comprehensive meta-analysis sheds new...

In a groundbreaking retrospective study published in BMC Cancer, researchers have unveiled compelling evidence supporting the pivotal role of chemotherapy...

In a groundbreaking nationwide study published in BMC Cancer, researchers have unveiled critical new insights into the real-world epidemiology, management,...

Abexinostat, a novel pan-histone deacetylase inhibitor, is emerging as a promising therapeutic agent for patients with relapsed or refractory B...

A landmark advancement in the treatment of newly diagnosed multiple myeloma patients has emerged from the recently presented ADVANCE clinical...

A groundbreaking study led by researchers at the Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School...